A novel approach that could dramatically slow down the spread of HIV by sexual contact
A precisely designed macromolecule that mimics the binding of HIV to immune system cells could be used to stop the virus from physically entering the body, according to a new study led by a materials scientist at Queen Mary University of London.
The researchers created the large molecule with several sugar molecules, known as glycopolymers. By using different sugars attached to the macromolecule in solution, the scientists were able to investigate which sugar molecules were the most effective in inhibiting the potential binding of the virus.
They then measured how the designed macromolecules compete with the virus to bind to the dendritic cells of the immune system at different concentrations.
“These are preliminary but encouraging results for potentially preventing the spread of the HIV by sexual contact,” said Dr Remzi Becerfrom Queen Mary’s School of Engineering and Materials Science.
“We’ve shown that our synthetic molecule binds to the immune cell, which in turn blocks the virus from attaching and entering. The precisely designed macromolecules could be an ingredient of a condom cream or vaginal gel to act as a physical barrier from allowing the virus into the body.”
The Latest on: Designer macromolecules
- Postnova AF2000 system offers reliable characterization of trace metal colloid distribution in the environment on February 22, 2018 at 2:32 am
The Postnova AF2000 is a high-performance Flow field-flow fractionation platform for separation of nanoparticles, macromolecules and proteins in complex matrices. Modular in design, the AF2000 incorporates the combined experience, expertise and ... […]
- Three University professors receive Sloan fellowship on February 16, 2018 at 10:37 pm
“It will allow us to see the dancing of macromolecules, molecules made through connections ... electronic and optical properties of materials at the atomic scale and to design new nanomaterials and devices. Diao works to reinvent methodologies for ... […]
- Neutron Study of Glaucoma Drugs Offers Clues About Enzyme Targets for Aggressive Cancers on February 12, 2018 at 12:19 pm
“We want to exploit the difference in charge, pH and temperature to see if we can design drugs that are more effective ... an enzyme and ligand—a molecule that binds to a biological macromolecule—and to analyzing the architecture of hydrogen-bonding ... […]
- Researchers combat cancer, Parkinson’s with CRISPR on February 8, 2018 at 12:00 am
In essence hormones, macromolecules and drugs use GCPRs to communicate at ... is and when they have completed an assigned task,” Qi said. “We’re trying to design smarter cells.” Second, ChaCha is reversible; a cell modified to a particular task ... […]
- New IBM-designed macromolecule could be a ‘magic bullet’ in the fight against viruses on May 13, 2016 at 5:10 am
That’s why IBM Research teamed up with the Institute of Bioengineering and Nanotechnology (IBN) to design a macromolecule that can treat viruses no matter how much they mutate. The researchers tested their macromolecule against Zika, Ebola, and dengue ... […]
- UPLC Bio System advances macromolecule analysis. on July 1, 2010 at 5:00 pm
New System Advances Macromolecule Analysis through Multiple-Mode ... UPLC users reported the need to design a new system with materials that address the unique challenges associated with macromolecule analysis. Accordingly, the ACQUITY UPLC H-Class Bio ... […]
via Google News and Bing News